If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJarvis Securities Regulatory News (JIM)

Share Price Information for Jarvis Securities (JIM)

Share Price is delayed by 15 minutes
Get Live Data
8.50    0.00 (0.00%)
Bid:
8.00
Ask:
9.00
Spread: 1.00 (12.50%)
Market Cap: £3.80m
JIM Live PriceLast checked at - London Stock Exchange

Intraday Jarvis Securities Share Chart

Update

Today 07:00

RNS Number : 6014L
Jarvis Securities plc
09 July 2026
 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Jarvis Securities plc

("Jarvis" or the "Company" and with its subsidiaries the "Group")

Update

On 7 July 2025 Jarvis announced (the "Announcement") that its wholly owned subsidiary Jarvis Investment Management Limited ("JIML") has sold its retail execution only brokerage business, for a total consideration of up to £11m to Interactive Investor Services Limited (the "Transaction"). The £9m initial consideration was paid to JIML straight away with the remaining £2 million of the consideration deferred for up to c.18 months and subject to potential adjustment for claims under the sale agreement ("Deferred Consideration"), 

The Company is pleased to announce that JIML has now received the first Deferred Consideration payment of £1m plus accrued interest, for a total payment of c.£1,029,000. The second and final Deferred Consideration payment, also of £1m (subject to potential adjustment for claims under the sale agreement) is due on or around 7 January 2027.

At this stage it is intended that JIML will retain these funds during the wind down process after which any surplus will be available for the benefit of the Company, if JIML has not been sold pursuant to the potential sale process announced on 5 May 2026. At this stage there can be no certainty as to the timing of any sale of JIML or that it will occur at all. Full details of the proposed disposal are set out in the Company's announcement of 5 May 2026.

Further updates will be provided in due course.

Steve Middleton, Non-executive Director of Jarvis Securities Plc, has approved this announcement and authorised its release.

Enquiries

Jarvis Securities plc

 01892 510 515

Andrew Grant

Zeus Capital (Nominated Adviser)

020 3829 5000 

Katy Mitchell / Liv Highton)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRSSWFAAEMSEDW
Date   Source Headline
30th Sep 200910:16 amRNSDirector's Significant Shareholding
31st Jul 20099:37 amRNSDirector's Dealings
29th Jul 20097:00 amRNSContract Win
28th Jul 200910:31 amRNSDividend Declaration - Record Date Amendment
28th Jul 20097:00 amRNSInterim Report - six months to 30 June 2009
10th Jun 200912:51 pmRNSDirector/PDMR Shareholding
10th Jun 20097:00 amRNSContract Win
29th May 200912:37 pmRNSDirector/PDMR Shareholding
20th May 20093:24 pmRNSDirector/PDMR Shareholding
18th May 20092:47 pmRNSDirector/PDMR Shareholding
14th Apr 200910:16 amRNSResult of General Meeting
14th Apr 20097:00 amRNSAGM Statement
1st Apr 20097:00 amRNSDirector/PDMR Shareholding
23rd Mar 20092:16 pmRNSAnnual Report and Accounts
4th Mar 20097:01 amRNSInterim Results, AGM Notice & Prior Distributions
4th Mar 20097:00 amRNSFinal Results
20th Feb 20097:00 amRNSContract Wins and Notice of Results
19th Dec 200812:15 pmRNSBoard Changes
17th Dec 20087:00 amRNSTrading Update
15th Oct 200812:18 pmRNSGeneral Meeting Result
15th Oct 200810:48 amRNSGeneral Meeting Statement
25th Sep 200810:00 amRNSChange of Nominated Adviser and Broker
30th Jul 200812:43 pmRNSResult of EGM
29th Jul 20087:00 amRNSInterim Report for the 6 mont
24th Jul 200812:31 pmRNSContract Win / Date of Interi
2nd Jul 20088:46 amRNSHolding(s) in Company/Directo
1st Jul 200812:11 pmRNSTransaction in Own Shares
24th Jun 20084:18 pmRNSTransaction in Own Shares
20th Jun 20089:46 amRNSNotice of EGM
12th Jun 200810:15 amRNSDirector/PDMR Shareholding
22nd May 20083:19 pmRNSRule 8.3- Jarvis Securities p
21st May 200812:38 pmRNSHolding(s) in Company
13th May 20086:00 amRNSStatement re Possible Offer
18th Apr 20087:00 amRNSContract Win
4th Apr 20087:01 amRNSTrading Update/Contract Wins
25th Mar 200812:54 pmRNSTransaction in Own Shares
17th Mar 20081:23 pmRNSTransaction in Own Shares
11th Mar 200812:07 pmRNSContract Win
10th Mar 200812:43 pmRNSTransaction in Own Shares
4th Mar 200811:21 amRNSDirector/PDMR Shareholding
22nd Feb 20084:11 pmRNSOwn Shares/Registered Office
7th Feb 20089:41 amRNSBoard Change/Director Dealing
29th Jan 20081:57 pmRNSPosting of Results
29th Jan 20081:19 pmRNSDirector/PDMR Shareholding
29th Jan 20087:01 amRNSResults to 31 December 2007
18th Jan 200812:00 pmRNSNotice of Results
9th Jan 200810:04 amRNSTransaction in Own Shares
26th Nov 20072:29 pmRNSTransaction in Own Shares
13th Nov 200710:31 amRNSTrading Statement
1st Oct 20071:19 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.